Canada in Science – February 7, 2020

Feb 07 17:02 2020 Print This Article

Welcome to your Canada in Science Review for February 7th, 2020!

Science.  2020. Jan 17; 367(6475): 301-305

Lipid-gated monovalent ion fluxes regulate endocytic traffic and support immune surveillance

Nat Cell Bio.  2020 Jan; 22(1): 120-134.

Mapping the proximity interaction network of the Rho-family GTPases reveals signaling pathways and regulatory mechanisms.

Nat Chem.  2020 Jan; 12(1): 48-55.

A multiplexed, electrochemical interface for gene-circuit-based sensors.

Nat Genet.  2020 Jan; 52(1): 40-47.

Loss of ADAMTS19 causes progressive non-syndromic heart valve disease.

Nat Genet.  2020 Jan 13.

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.

As with all our posts, please see our full legal disclaimer.

Read More

About Article Author

Cross Border Biotech Blog

Bloom Burton & Co. is Canada's leading biotechnology and healthcare-specialized investment banking firm, which exists to accelerate returns in healthcare. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deeper level of diligence, which combined with a creative and entrepreneurial approach, leads to the right monetization events for companies and investors. Bloom Burton provides capital raising, M&A advisory, equity research, management consulting, direct investments through equity and debt funds, and company creation services.


Related Items

Market Update: Investors Optimistic as Global Economies Reopen

The quickest bear market in the history of the US S&P 500 turned into the best 50-day bull market rally in history in May. By market close on June 3, 2020, the S&P 500 Index was up 37.7% from its March 23, 2020 low. This bullish investor sentiment has been based on the continued decline in new coro ...

“E” vs “SG” in ethical investing: how sustainable is mollification-by-cherrypicking

In the great game of whack-a-mole that is capital raising in Canada’s oil patch, it must be frustrating, for those whose full-time job when there isn’t a global pandemic is whacking the moles of ESG criteria on which they feel their companies may be vulnerable to criticism and hence subject to ...

Did wind-generated electricity displace gas-generated electricity in Ontario in June 2019?

Financiers of green energy projects often claim in public filings that the energy generated by the projects they have financed has avoided some definite number of tons of CO2 emissions. Run the numbers, and you usually find they have assumed some annual capacity factor, say 35 percent in the case o ...

Wind power in Ontario, June 2019: dancing with hydro

Last time I noted the operation of one particular Ontario gas-fired generating plant in relation with provincial electrical demand, total in-province generation, “market” price, and aggregate wind output. I showed that although through the month of June 2019 total generation exceeded Ontario de ...

A deep retrofit of homes and buildings is the megaproject Canada needs

Ramping down carbon emissions from homes and buildings can help us rebuild Canada’s economy after the pandemic. ...

Rebuilding Canada’s economy includes energy resiliency in remote communities (blog)

This is the moment to create a roadmap for a society that is more resilient to these macro shocks – whether they are brought about by a pandemic or climate change. Canada’s response must support a more resilient, healthier economy that is competitive and shows economic strength in a decarbonize ...

BRC Webinar Series

Join the Business Renewables Centre-Canada and some of our founding members for our inaugural BRC Webinar Series to learn about the basics of corporate renewable procurement and what its future in Canada looks like. ...

5 from 5i: Shopify displaces RBC to become Canada's most valuable company

Weekly stock market update & five stock related articles we thought were a must-read this week ...

Zymeworks ticks all the boxes for a biopharma investment, Paradigm says

Zymeworks (Zymeworks Stock Quote, Chart, News NYSE:ZYME) has what investors should be looking for in a biopharmaceutical company, according to Paradigm Capital analyst Corey Hammill, namely, a strong balance sheet and a healthy-looking pipeline. The analyst reviewed Zymeworks latest quarterly resul ...

Q4 2019 Share Price Performance

Q4 2019 Share Price Performance Healthcare Stocks Surge  In this blog post, the Bloom Burton equity research team summarizes the performance of the Canadian healthcare sector during 4Q-2019, and provides commentary on select stock movements and overall market trends.  Inclusion Criteria  Our ana ...

IMV gets price target cut from Raymond James

New clinical results from biopharm company IMV (IMV Stock Quote, Chart, News TSX:IMV) signal a less straightforward path to commercialization than previously assumed, according to Raymond James analyst David Novak, who reviewed the results in an update to clients on Wednesday. Dartmouth, Nova Scoti ...

Yikes to the Year End!

Originally published in December 2019 Clearly, there is more going on these days in Washington, D.C. than just the impeachment hearings, and activities this week made that point clear. In the span of only a few days, we saw progress on two key issues – the China 301 tariffs and the U.S.-Mexico-Ca ...